Published in Pain and Central Nervous System Week, November 24th, 2008
"Therefore, we evaluated the safety of continuing d-drug therapy. In a US cohort, we compared the rates of worsening neuropathic symptoms and signs in HIV-infected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week